NuVasive bolsters spinal portfolio with 2 FDA clearances, 1 product launch

NuVasive on May 5 expanded its advanced materials science implant portfolio with two FDA 510(k) clearances and one device launch.

Advertisement

Three things to know:

1. The FDA provided clearance for the company’s Modulus ALIF, a porous titanium implant, and Cohere TLIF-O, a porous PEEK implant.

2. NuVasive launched the Modulus XLIF dual sided plate, which is a low-profile, anti-migration plate that allows for two points of fixation in extreme lateral interbody fusion surgeries.

3. NuVasive’s AMS implant portfolio features devices designed to improve the osseointegration and biomechanical properties of materials used in spine surgeries.

More articles on devices:
Geoff Martha, Kevin Lobo & more: 5 CEOs to know in the spine industry
Wright Medical inches toward sale, makes pay cuts due to pandemic: 5 updates
How COVID-19 has affected Medtronic, Stryker, Johnson & Johnson’s shares over the last month

Advertisement

Next Up in Spinal Tech

  • Zavation Medical has acquired ChoiceSpine, and Derek Kuyper will be CEO of the combined company, according to a Feb. 26…

  • Carlsmed saw significant gains in fourth-quarter and 2025 revenue, according to financial results posted Feb. 25. Five things to know:…

Advertisement

Comments are closed.